Related content

Early decrease in serum IV-7S levels during IFN treatment predicts anti-fibrogenic effect in nonresponders with chronic hepatitis C

By Abe Shintaro   Narita Ryouichi   Hiura Masaaki   Jia Dong Mei   Tabaru Akinari   Otsuki Makoto  

Journal of Gastroenterology, Vol. 39, Iss. 3, 2004-03 ,pp. : 247-254

Springer Publishing Company

Access to resources Recommend Favorite

High levels of serum antibodies to cell surface proteins of Helicobacter pullorum and Helicobacter pylori in hepatitis C virus-infected patients

By Lonngren Vincent   Nilsson Ingrid   Verbaan Hans   Wadstrom Torkel   Ljungh Åsa  

Scandinavian Journal of Gastroenterology, Vol. 44, Iss. 4, 2009-04 ,pp. : 505-506

Informa Healthcare

Access to resources Recommend Favorite

Characteristics of complete responders to interferon among patients with chronic hepatitis C with high serum levels of RNA

By Ide T.   Sata M.   Suzuki H.   Uchimura Y.   Shirachi M.   Adachi N.   Tanikawa K.  

International Hepatology Communications, Vol. 7, Iss. 1, 1997-05 ,pp. : 19-27

Elsevier

Access to resources Recommend Favorite

Effects of interferon treatment on the glucose metabolism of patients with chronic hepatitis C

By Nemesanszky E.   Pusztay M.   Csepregi A.  

European Journal of Internal Medicine, Vol. 11, Iss. 3, 2000-06 ,pp. : 151-155

Elsevier

Access to resources Recommend Favorite

Association of Serum Adipocytokines with Hepatic Steatosis and Fibrosis in Patients with Chronic Hepatitis C

By  

Digestion, Vol. 83, Iss. 1-2, 2010-09 ,pp. : 32-40

Karger

Access to resources Recommend Favorite